Nektar Therapeutics NKTR Business Segments — D&A

Similar metrics at other companies

VFFAll Other Segments — D&A

$785K-46.1%

MPAAAll Other Segments — D&A

$552K+168%

KEXAll Other Segments — D&A

$1.82M-3.2%

SRPTAll Other Segments — D&A

$10.41M-4.0%

UNFAll Other Segments — D&A

$702K-7.3%

OGEAll Other Segments — D&A

$0—

FAQ

What is Nektar Therapeutics's business segments — D&A?

Nektar Therapeutics (NKTR) reported business segments — D&A of $121K in Q1 2026.

How has Nektar Therapeutics's business segments — D&A changed year-over-year?

Nektar Therapeutics's business segments — D&A decreased by 69.3% year-over-year, from $394K to $121K.

What is the long-term trend for Nektar Therapeutics's business segments — D&A?

Over 2 years (2023 to 2025), Nektar Therapeutics's business segments — D&A has grown at a -52.9% compound annual growth rate (CAGR), from $4.05M to $899K.

What does business segments — D&A mean?

Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the segment. This non-cash expense reflects the consumption of capital investments required to support the segment's research, development, or operational activities. It is a key indicator of the segment's capital intensity and asset utilization.